Title | Type | SJR | H index | Total Docs. (2008) | Total Docs. (3years) | Total Refs. (2008) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2008) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Toxicology and Applied Pharmacology | journal | 1.318 Q1 | 189 | 366 | 920 | 17711 | 3660 | 902 | 3.60 | 48.39 | |
52 | Cardiovascular Drug Reviews | journal | 1.317 Q1 | 54 | 0 | 70 | 0 | 273 | 68 | 4.52 | 0.00 | |
53 | PharmacoEconomics | journal | 1.257 Q1 | 118 | 84 | 331 | 3622 | 973 | 279 | 2.50 | 43.12 | |
54 | Expert Opinion on Investigational Drugs | journal | 1.249 Q1 | 117 | 173 | 445 | 12481 | 1750 | 418 | 3.98 | 72.14 | |
55 | Behavioural Pharmacology | journal | 1.247 Q1 | 87 | 84 | 235 | 4587 | 671 | 232 | 2.67 | 54.61 | |
56 | Drug Safety | journal | 1.221 Q1 | 140 | 104 | 287 | 4704 | 1111 | 249 | 3.42 | 45.23 | |
57 | Clinical Therapeutics | journal | 1.213 Q1 | 150 | 273 | 685 | 8134 | 2565 | 619 | 3.49 | 29.79 | |
58 | Expert Opinion on Biological Therapy | journal | 1.198 Q1 | 102 | 171 | 423 | 14412 | 1417 | 421 | 3.76 | 84.28 | |
59 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.195 Q1 | 82 | 13 | 37 | 2583 | 142 | 37 | 3.65 | 198.69 | |
60 | Antiviral Research | journal | 1.194 Q1 | 151 | 137 | 307 | 6455 | 1179 | 305 | 3.69 | 47.12 | |
61 | Pharmacological Research | journal | 1.191 Q1 | 169 | 114 | 412 | 6305 | 1538 | 406 | 3.80 | 55.31 | |
62 | Current Drug Metabolism | journal | 1.182 Q1 | 122 | 114 | 183 | 11387 | 1012 | 177 | 5.06 | 99.89 | |
63 | Prostaglandins and Other Lipid Mediators | journal | 1.177 Q1 | 86 | 35 | 202 | 1844 | 538 | 200 | 2.54 | 52.69 | |
64 | Cardiovascular Drugs and Therapy | journal | 1.158 Q1 | 79 | 63 | 180 | 2660 | 435 | 151 | 2.35 | 42.22 | |
65 | Experimental and Clinical Psychopharmacology | journal | 1.157 Q1 | 101 | 56 | 149 | 3445 | 357 | 148 | 2.48 | 61.52 | |
66 | Current Opinion in Investigational Drugs | journal | 1.135 Q1 | 83 | 126 | 393 | 8936 | 1223 | 361 | 3.56 | 70.92 | |
67 | Advances in Pharmacology | journal | 1.129 Q1 | 86 | 17 | 76 | 2561 | 187 | 70 | 2.88 | 150.65 | |
68 | BioDrugs | journal | 1.121 Q1 | 79 | 38 | 123 | 3093 | 420 | 117 | 2.97 | 81.39 | |
69 | Journal of Clinical Pharmacology | journal | 1.093 Q2 | 130 | 142 | 463 | 4481 | 1765 | 448 | 3.59 | 31.56 | |
70 | Inflammation and Allergy - Drug Targets | journal | 1.085 Q2 | 55 | 35 | 62 | 3477 | 157 | 57 | 2.53 | 99.34 | |
71 | Cancer Chemotherapy and Pharmacology | journal | 1.081 Q2 | 122 | 268 | 590 | 8806 | 1737 | 585 | 2.88 | 32.86 | |
72 | British Journal of Clinical Pharmacology | journal | 1.073 Q2 | 167 | 288 | 645 | 7173 | 1945 | 522 | 2.93 | 24.91 | |
73 | Current Opinion in Molecular Therapeutics | journal | 1.069 Q2 | 67 | 71 | 223 | 4806 | 612 | 201 | 3.10 | 67.69 | |
74 | ChemMedChem | journal | 1.047 | 119 | 211 | 452 | 9072 | 1239 | 448 | 3.17 | 43.00 | |
75 | Drug Metabolism and Pharmacokinetics | journal | 1.045 Q2 | 75 | 64 | 178 | 1900 | 604 | 174 | 3.06 | 29.69 | |
76 | Journal of Pharmacological Sciences | journal | 1.044 Q2 | 101 | 221 | 545 | 7147 | 1480 | 536 | 2.76 | 32.34 | |
77 | Expert Review of Vaccines | journal | 1.038 Q2 | 105 | 137 | 255 | 10660 | 762 | 232 | 2.97 | 77.81 | |
78 | Microbial Drug Resistance | journal | 1.038 Q2 | 78 | 44 | 148 | 1304 | 278 | 148 | 2.00 | 29.64 | |
79 | Journal of Ethnopharmacology | journal | 1.024 Q2 | 231 | 414 | 1343 | 16251 | 4048 | 1329 | 2.69 | 39.25 | |
80 | Naunyn-Schmiedeberg's Archives of Pharmacology | journal | 1.023 Q2 | 99 | 131 | 266 | 7602 | 733 | 257 | 2.99 | 58.03 | |
81 | European Journal of Pharmacology | journal | 1.018 Q2 | 203 | 888 | 2111 | 40137 | 6367 | 2108 | 3.09 | 45.20 | |
82 | Pharmaceutical Statistics | journal | 1.007 Q2 | 46 | 29 | 92 | 422 | 96 | 76 | 1.20 | 14.55 | |
83 | Journal of Biomolecular Screening | journal | 1.000 Q2 | 86 | 95 | 293 | 2340 | 833 | 291 | 2.69 | 24.63 | |
84 | Journal of Pharmacokinetics and Pharmacodynamics | journal | 0.993 Q2 | 70 | 32 | 111 | 930 | 254 | 106 | 2.51 | 29.06 | |
85 | Journal of Cardiovascular Pharmacology | journal | 0.992 Q2 | 109 | 155 | 559 | 6346 | 1377 | 548 | 2.59 | 40.94 | |
86 | Pharmacogenomics | journal | 0.988 Q2 | 100 | 182 | 375 | 9640 | 1277 | 331 | 3.49 | 52.97 | |
87 | Expert Opinion on Emerging Drugs | journal | 0.986 Q2 | 54 | 43 | 144 | 5144 | 459 | 144 | 3.44 | 119.63 | |
88 | Anti-Cancer Drugs | journal | 0.973 Q2 | 102 | 130 | 450 | 4847 | 1260 | 448 | 2.63 | 37.28 | |
89 | European Journal of Medicinal Chemistry | journal | 0.962 Q2 | 203 | 320 | 489 | 10604 | 1505 | 489 | 2.87 | 33.14 | |
90 | Vascular Pharmacology | journal | 0.957 Q2 | 108 | 53 | 304 | 2501 | 818 | 295 | 2.68 | 47.19 | |
91 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.952 Q2 | 100 | 123 | 187 | 10962 | 769 | 182 | 3.74 | 89.12 | |
92 | Chirality | journal | 0.936 Q2 | 83 | 130 | 333 | 4840 | 785 | 330 | 2.23 | 37.23 | |
93 | Journal of Pharmacological and Toxicological Methods | journal | 0.909 Q2 | 83 | 50 | 214 | 2051 | 570 | 205 | 2.52 | 41.02 | |
94 | Canadian Journal of Physiology and Pharmacology | journal | 0.904 Q2 | 95 | 110 | 421 | 3959 | 781 | 412 | 1.89 | 35.99 | |
95 | Clinical and Experimental Pharmacology and Physiology | journal | 0.886 Q2 | 115 | 251 | 638 | 9647 | 1507 | 628 | 2.49 | 38.43 | |
96 | Phytomedicine | journal | 0.884 Q2 | 141 | 153 | 384 | 4394 | 1091 | 369 | 2.74 | 28.72 | |
97 | Journal of NeuroImmune Pharmacology | journal | 0.863 Q2 | 91 | 33 | 86 | 1506 | 218 | 82 | 2.53 | 45.64 | |
98 | Clinical Neuropharmacology | journal | 0.859 Q2 | 85 | 58 | 192 | 1480 | 631 | 174 | 2.80 | 25.52 | |
99 | European Journal of Clinical Pharmacology | journal | 0.852 Q2 | 123 | 165 | 509 | 5627 | 1397 | 454 | 2.59 | 34.10 | |
100 | Steroids | journal | 0.810 Q2 | 114 | 174 | 368 | 6981 | 993 | 366 | 2.65 | 40.12 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®